WHO ICTRP trial
Mri-Assisted high intensity focused ultrasound metastatic Liver Tumor Ablation…
NL-OMON41228 · Overview of Medical Research in the Netherlands (NL-OMON)
Key facts
| Trial ID | NL-OMON41228 |
|---|---|
| Public title | Mri-Assisted high intensity focused ultrasound metastatic Liver Tumor Ablation (MALTA study) |
| Scientific title | Mri-Assisted high intensity focused ultrasound metastatic Liver Tumor Ablation (MALTA study) - MALTA |
| Primary sponsor | Universitair Medisch Centrum Utrecht |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Study type | Interventional |
| Countries | The Netherlands |
| Conditions | Colerectal liver cancer; liver cancer;10019815;10027476;10019818;Colerectal liver cancer; liver cancer |
| Interventions | MR-HIFU is used to ablate (part of) one metastatic liver tumor. HIFU ablation uses focused ultrasound waves to non-invasively heat and thermally ablate tissue. MR guidance is used for treatment planning, treatment monitoring (temperature… |
| Registration date | Apr 30, 2015 |
| Target size | 50 |
| Secondary IDs | NL45332.041.13;NTR4473 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: